BioSig Technologies, Inc. announced a private placement of a non convertible promissory note for a gross proceeds of $500,000 on March 7, 2024. The note is due on March 7, 2026, and provides for 12% annual interest rate. The note is issued at a principal amount of $1,000,000.

The note was issued pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended.